Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Brechbiel

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
AIMS Medical Science|February 10, 2016
Application of <sup>212</sup>Pb for Targeted α-particle Therapy (TAT): Pre-clinical and Mechanistic Understanding through to Clinical TranslationKwon Yong, Martin Brechbiel
Expert Opinion on Therapeutic Targets|June 5, 2003
Antiangiogenic therapy through copper chelationMary Sproull, Martin Brechbiel, Kevin Camphausen
Investigative Radiology|March 30, 2002
Identifying tumor vascular permeability heterogeneity with magnetic resonance imaging contrast agentsMichael Aref, Martin Brechbiel, Erik C Wiener
Investigative Radiology|March 8, 2002
Theory and practice of imaging saturable binding sitesWilliam C Eckelman, Joseph A Frank, Martin Brechbiel
Investigative Radiology|September 23, 2003
Characteristics of a new MRI contrast agent prepared from polypropyleneimine dendrimers, generation 2Steven J Wang, Martin Brechbiel, Erik C Wiener
Journal of Magnetic Resonance Imaging : JMRI|July 12, 2007
MRI of tumor angiogenesisTristan Barrett, Martin Brechbiel, Marcelino Bernardo, et al.
European Journal of Radiology|August 26, 2006
Macromolecular MRI contrast agents for imaging tumor angiogenesisTristan Barrett, Hisataka Kobayashi, Martin Brechbiel, et al.
Academic Radiology|August 22, 2002
Imaging folate binding protein expression with MRIErik C Wiener, Sheela D Konda, Steven Wang, et al.
Investigative Radiology|March 30, 2002
Biodistribution of a 153 Gd-folate dendrimer, generation = 4, in mice with folate-receptor positive and negative ovarian tumor xenograftsSheela D Konda, Steven Wang, Martin Brechbiel, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 2004
Are radiation oncologists serious about systemic radiation therapy and if not, should we be?Paul E Wallner, C Norman Coleman, Martin Brechbiel, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
AIMS Medical Science|February 10, 2016
Application of <sup>212</sup>Pb for Targeted α-particle Therapy (TAT): Pre-clinical and Mechanistic Understanding through to Clinical TranslationKwon Yong, Martin Brechbiel
Expert Opinion on Therapeutic Targets|June 5, 2003
Antiangiogenic therapy through copper chelationMary Sproull, Martin Brechbiel, Kevin Camphausen
Investigative Radiology|March 30, 2002
Identifying tumor vascular permeability heterogeneity with magnetic resonance imaging contrast agentsMichael Aref, Martin Brechbiel, Erik C Wiener
Investigative Radiology|March 8, 2002
Theory and practice of imaging saturable binding sitesWilliam C Eckelman, Joseph A Frank, Martin Brechbiel
Investigative Radiology|September 23, 2003
Characteristics of a new MRI contrast agent prepared from polypropyleneimine dendrimers, generation 2Steven J Wang, Martin Brechbiel, Erik C Wiener
Journal of Magnetic Resonance Imaging : JMRI|July 12, 2007
MRI of tumor angiogenesisTristan Barrett, Martin Brechbiel, Marcelino Bernardo, et al.
European Journal of Radiology|August 26, 2006
Macromolecular MRI contrast agents for imaging tumor angiogenesisTristan Barrett, Hisataka Kobayashi, Martin Brechbiel, et al.
Academic Radiology|August 22, 2002
Imaging folate binding protein expression with MRIErik C Wiener, Sheela D Konda, Steven Wang, et al.
Investigative Radiology|March 30, 2002
Biodistribution of a 153 Gd-folate dendrimer, generation = 4, in mice with folate-receptor positive and negative ovarian tumor xenograftsSheela D Konda, Steven Wang, Martin Brechbiel, et al.
International Journal of Radiation Oncology, Biology, Physics|September 1, 2004
Are radiation oncologists serious about systemic radiation therapy and if not, should we be?Paul E Wallner, C Norman Coleman, Martin Brechbiel, et al.
Pageof 2